0.7845
Schlusskurs vom Vortag:
$0.787
Offen:
$0.783
24-Stunden-Volumen:
153.87K
Relative Volume:
0.03
Marktkapitalisierung:
$34.97M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-3.9225
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
+5.56%
1M Leistung:
+22.48%
6M Leistung:
+60.82%
1J Leistung:
-61.35%
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Vergleichen Sie HBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
HBIO
Harvard Bioscience Inc
|
0.7845 | 35.08M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
562.75 | 197.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.76 | 55.76B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.85 | 38.93B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.47 | 35.90B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
268.62 | 19.36B | 2.96B | 487.70M | 344.00M | 6.6758 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Eingeleitet | Northland Capital | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Herabstufung | Janney | Buy → Neutral |
| 2018-01-24 | Bestätigt | Janney | Buy |
| 2018-01-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-11-17 | Eingeleitet | Singular Research | Buy |
| 2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
Harvard Bioscience secures $40 million credit facility from BroadOak By Investing.com - Investing.com Nigeria
Harvard Bioscience, Inc. Appoints Bill Snider as Member of Class III of the Board and as Member of Compensation Committee, Effective December 17, 2025 - marketscreener.com
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package - marketscreener.com
Harvard Bioscience, Inc. announced that it expects to receive $40 million in funding from BroadOak Capital Partners, LLC - marketscreener.com
Harvard Bioscience announces the successful completion of debt refinancing - marketscreener.com
Harvard Bioscience secures $40 million credit facility from BroadOak - Investing.com India
Harvard Bioscience enters loan agreement with some lenders - marketscreener.com
Harvard Bioscience Secures $40M Loan Agreement - TipRanks
Harvard Bioscience Appoints William A. Snider to Board of Directors - TradingView — Track All Markets
Harvard Bioscience (NASDAQ: HBIO) signs loan deal and names director to board - Stock Titan
Life science tools firm lands $40M boost and adds veteran investor - Stock Titan
Harvard Bioscience Earnings Notes - Trefis
What drives Harvard Bioscience Inc HBI stock priceIndustrial Stocks Review & High Profit Trading Plans - earlytimes.in
Its Stock Has Paid Off Big Time For Harvard Bioscience Inc - setenews.com
Is Harvard Bioscience Inc. (HBI) stock cheap vs fundamentalsJuly 2025 Pullbacks & Low Risk High Reward Ideas - Newser
Can Harvard Bioscience Inc. stock continue upward trendJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Can Harvard Bioscience Inc. (HBI) stock stage a strong rebound this quarterJuly 2025 Highlights & High Accuracy Investment Entry Signals - Newser
Research Analysts’ Weekly Ratings Updates for Harvard Bioscience (HBIO) - Defense World
Further Upside For Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Introduce Price Risks After 27% Bounce - simplywall.st
Will Harvard Bioscience Inc. (HBI) stock sustain bullish trend into 2025 - Newser
How Harvard Bioscience Inc. stock benefits from tech adoptionJuly 2025 Setups & Entry and Exit Point Strategies - Newser
What Wall Street predicts for Harvard Bioscience Inc. stock priceWeekly Trade Review & Verified Technical Signals - Newser
It is Poised to be a Bull Market for Harvard Bioscience Inc (HBIO) - Setenews
Holdings of Harvard Bioscience Inc (HBIO) are aligned with the stars - Setenews
Is Harvard Bioscience Inc. (HBI) stock worth buying before Fed actionQuarterly Profit Report & Weekly High Conviction Ideas - newser.com
Key resistance and support levels for Harvard Bioscience Inc.Quarterly Profit Report & Weekly Market Pulse Updates - newser.com
How Harvard Bioscience Inc. (HBI) stock compares with tech leadersPortfolio Value Summary & Weekly Stock Breakout Alerts - newser.com
Will Harvard Bioscience Inc. (HBI) stock benefit from mergers2025 Buyback Activity & Expert Approved Trade Ideas - newser.com
Will Harvard Bioscience Inc. stock gain from strong economyWeekly Risk Summary & Daily Technical Forecast Reports - newser.com
How Harvard Bioscience Inc. stock trades before earningsJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - newser.com
Using fundamentals and technicals on Harvard Bioscience Inc.July 2025 Levels & Reliable Breakout Forecasts - newser.com
Analyzing Harvard Bioscience Inc. with risk reward ratio chartsJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Harvard Bioscience (NASDAQ:HBIO) Upgraded to Buy at Wall Street Zen - Defense World
Wall Street Zen Upgrades Harvard Bioscience (NASDAQ:HBIO) to “Buy” - Defense World
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):